Although in vivo experiments show that p38 inhibitors can suppress tumor progression in many cases, it remains possible that the inhibition of this kinase would favor tumor initiation in other tissues subjected to oncogenic stimuli. This evidence concerns the gene MAPK14 and neoplasm.